| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer, Secretary | General Counsel and Secretary | General Counsel and Secretary
1 company
Bookman Michael serves as a Chief Legal Officer, Secretary at IMRX. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $33K at current prices.
Historically, Bookman Michael's trades have earned a below-average insider score of 49/100 across 3 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +3.4%.
The biggest single holding is IMRX (~$33K) as Chief Legal Officer, Secretary. Net of sales, the recent Form 4 record there shows accumulation of 3,422 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | IMRX Immuneering Corp | Chief Legal Officer, Secretary | Buy | 1,020 | $6.83 | $6,966.50 | +26.5% | +5.8% | -36.6% | |
| May 17, 2022 | IMRX Immuneering Corp | General Counsel and Secretary | Buy | 1,000 | $4.88 | $4,880.00 | +71.3% | +30.6% | +71.1% | |
| Aug 3, 2021 | IMRX Immuneering Corp | General Counsel and Secretary | Buy | 1,402 | $15.00 | $21,030.00 | New | +40.0% | -64.3% |